{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:41:24Z","timestamp":1793770884721,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canrad.2025.104667","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:26:14Z","timestamp":1750742774000},"page":"104667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Failure patterns analysis of three-dimensional radiotherapy for stage IV non-small cell lung cancer primary tumours"],"prefix":"10.1016","volume":"29","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 23","key":"10.1016\/j.canrad.2025.104667_bib0160","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/cncr.29045","article-title":"Analysis of stage and clinical\/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system","volume":"120","author":"Chen","year":"2014","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2025.104667_bib0165","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.canrad.2025.104667_bib0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3816\/CLC.2006.n.045","article-title":"Update in the treatment of brain metastases from lung cancer","volume":"8","author":"Schwer","year":"2007","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.canrad.2025.104667_bib0175","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0180","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.pmed.0020017","article-title":"KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.canrad.2025.104667_bib0185","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02841860802662722","article-title":"Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis","volume":"48","author":"Rusthoven","year":"2009","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104667_bib0190","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/j.ijrobp.2012.04.045","article-title":"The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB\/IV non-small cell lung carcinoma","volume":"84","author":"Higginson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"010","key":"10.1016\/j.canrad.2025.104667_bib0195","first-page":"1141","article-title":"Analysis of results of stereotactic radiotherapy for 43 cases of oligometastatic NSCLC","volume":"026","author":"Hu","year":"2017","journal-title":"Chin J Radiat Oncol"},{"issue":"18","key":"10.1016\/j.canrad.2025.104667_bib0200","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1002\/cam4.4133","article-title":"Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1186\/s12885-016-2952-3","article-title":"Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic stage IV non-small cell lung cancer? Secondary analysis of two prospective studies","volume":"16","author":"Su","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104667_bib0210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijrobp.2015.08.012","article-title":"Three-dimensional radiation therapy to the primary tumor with concurrent chemotherapy in patients with stage IV non-small cell lung cancer: results of a multicenter phase 2 study from PPRA-RTOG, China","volume":"93","author":"Su","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104667_bib0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2018.11.017","article-title":"Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: a systematic review and meta-analysis","volume":"126","author":"Petrelli","year":"2018","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.canrad.2025.104667_bib0220","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jtho.2018.07.098","article-title":"Progression-free survival and overall survival beyond 5 years of NSCLC patients with synchronous oligometastases treated in a prospective phase II trial (NCT01282450)","volume":"13","author":"De Ruysscher","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104667_bib0225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.canrad.2025.104667_bib0230","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.canrad.2025.104667_bib0235","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.canrad.2025.104667_bib0240","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2025.104667_bib0245","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2407-13-474","article-title":"Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study","volume":"13","author":"Su","year":"2013","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2025.104667_bib0250","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/JTO.0b013e31811f4703","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer","volume":"2","author":"Postmus","year":"2007","journal-title":"Thorac Oncol"},{"issue":"02","key":"10.1016\/j.canrad.2025.104667_bib0255","first-page":"122","article-title":"Analysis of the radiotherapy significance of the characteristics of distant metastasis in 546 patients with stage IV non-small cell lung cancer","volume":"21","author":"Li","year":"2012","journal-title":"Chin J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0265","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104667_bib0270","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.canrad.2025.104667_bib0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1748-717X-6-166","article-title":"Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation","volume":"6","author":"Arrieta","year":"2011","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104667_bib0280","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2021.02.044","article-title":"Prophylactic cranial irradiation reduces brain metastases and improves overall survival in high-risk metastatic non-small cell lung cancer patients: a randomized phase 2 study (PRoT-BM trial)","volume":"110","author":"Arrieta","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2025.104667_bib0285","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.cllc.2019.06.024","article-title":"Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT","volume":"20","author":"H\u00f6rner-Rieber","year":"2019","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13014-020-01590-8","article-title":"Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer","volume":"15","author":"Taugner","year":"2020","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40880-017-0261-0","article-title":"Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy","volume":"36","author":"Ma","year":"2017","journal-title":"Chin J Cancer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104667_bib0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104667_bib0305","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2018.11.017","article-title":"Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: a systematic review and meta-analysis","volume":"126","author":"Petrelli","year":"2018","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.canrad.2025.104667_bib0310","first-page":"1051","article-title":"A prospective, multicenter phase II clinical study of concurrent 3DRT chemotherapy for stage IV NSCLC: reanalysis of survival in different pathological types (PPRA-RTOG003)","volume":"25","author":"Deng","year":"2016","journal-title":"Chin J Radiat Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:40:02Z","timestamp":1762368002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1278321825000836"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104667","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Failure patterns analysis of three-dimensional radiotherapy for stage IV non-small cell lung cancer primary tumours","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104667"}}